Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline
dc.creator | McMillin, Matthew | |
dc.creator | Frampton, Gabriel | |
dc.creator | Thompson, Michelle | |
dc.creator | Galindo, Cheryl | |
dc.creator | Standeford, Holly | |
dc.creator | Whittington, Eric | |
dc.creator | Alpini, Gianfranco | |
dc.creator | DeMorrow, Sharon | |
dc.date.accessioned | 2019-10-08T21:04:46Z | |
dc.date.available | 2019-10-08T21:04:46Z | |
dc.date.issued | 2014 | |
dc.identifier.issn | 1742-2094 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/179361 | |
dc.format.extent | 0 | en |
dc.publisher | Journal of Neuroinflammation | |
dc.relation.ispartof | 1foldr Import 2019-10-08 Batch 3 | en |
dc.relation.uri | 10.1186/1742-2094-11-121 | en |
dc.title | Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline | en |